8378511falsePharmaceutical services.2024-02-012025-01-31http://www.companieshouse.gov.uk/2024-01-31http://www.companieshouse.gov.uk/cd:Director12024-02-012025-01-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-02-012025-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-01-31http://www.companieshouse.gov.uk/2024-02-012025-01-31http://www.companieshouse.gov.uk/2024-01-31http://www.companieshouse.gov.uk/2025-01-31http://www.companieshouse.gov.uk/cd:FullAccounts2024-02-012025-01-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-02-012025-01-31http://www.companieshouse.gov.uk/cd:Micro-entities2024-02-012025-01-31iso4217:GBPxbrli:sharesxbrli:pure

Registered number: 8378511

RAR Pharmaceutics Ltd

ACCOUNTS

FOR THE YEAR ENDED 31/01/2025

Prepared By:

Avalon Partners Ltd

35 Watling St Rd

Preston

PR2 8EA

RAR Pharmaceutics Ltd

Registered Number: 8378511
BALANCE SHEET AT 31/01/2025
						2025				2024
						£				£
Fixed assets						340				453
Current assets				857				1,006
Creditors: amounts falling due within one year				(1,031)				(170)
Net Current (Liabilities) / Assets						(174)				836
Total assets less current liabilities						166				1,289
Net Assets						166				1,289
Capital and reserves						166				1,289
Average Number of Employees
During the year the average number of employees was 1.
Company information
Private company limited by shares registered in EW - England and Wales, registered number 8378511. Registered office 18 Avenue Rd, Darlaston, West Midlands, WS10 8AR, UK
For the year ending 31/01/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the micro-entities regime.
These accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 23/10/2025 and signed on their behalf by
.............................
R A Ravat
Director